Skip to main content
Top
Published in: BMC Hematology 1/2018

Open Access 01-12-2018 | Debate

Experimental folate deficiency in human subjects: what is the influence of vitamin C status on time taken to develop megaloblastic anaemia?

Author: Paul Henry Golding

Published in: BMC Hematology | Issue 1/2018

Login to get access

Abstract

Background

In 1962 Victor Herbert developed megaloblastic anaemia four months after commencing a severely folate-deficient diet whereas, in his self-experiment 50 years later, this author took 19 months to fully deplete his liver folate store. This author proposed that his own larger initial liver folate store, due to his vegetarian diet and consumption of fortified foods, was the cause of the time difference.

Main text

This author now proposes that Herbert was also likely to have been deficient in vitamin C, thus shortening the time taken to develop folate deficiency. Several human experiments have confirmed the role of vitamin C in protecting reduced forms of folate from oxidation. Although there has historically been no consensus on the required intake of vitamin C, and official recommendations set a level below that required to ensure plasma saturation, recent research supports an intake that would ensure saturation. There have been no longitudinal experiments on human subjects since the introduction of voluntary or mandatory folic acid fortification of food, and the few published models differ significantly in their estimates of human liver folate storage capacity.

Conclusion

Because of the importance of folate in one-carbon metabolism, the potential influence of vitamin C intake on the time taken to deplete the liver folate store should be experimentally investigated.
Appendix
Available only for authorised users
Literature
1.
go back to reference Herbert V. Experimental nutritional folate deficiency in man. Trans Assoc Am Phys. 1962;75:307–20.PubMed Herbert V. Experimental nutritional folate deficiency in man. Trans Assoc Am Phys. 1962;75:307–20.PubMed
2.
go back to reference Herbert V. The 1986 Herman award lecture. Nutrition science as a continually unfolding story: the folate and vitamin B-12 paradigm. Am J Clin Nutr. 1987a;46(3):387–402.CrossRefPubMed Herbert V. The 1986 Herman award lecture. Nutrition science as a continually unfolding story: the folate and vitamin B-12 paradigm. Am J Clin Nutr. 1987a;46(3):387–402.CrossRefPubMed
3.
go back to reference Herbert V. Recommended dietary intakes (RDI) of folate in humans. Am J Clin Nutr. 1987b;45(4):661–70.CrossRefPubMed Herbert V. Recommended dietary intakes (RDI) of folate in humans. Am J Clin Nutr. 1987b;45(4):661–70.CrossRefPubMed
4.
go back to reference Steinberg S. Mechanisms of folate homeostasis. Am J Phys. 1984;246(4 Pt 1):G319–24. Steinberg S. Mechanisms of folate homeostasis. Am J Phys. 1984;246(4 Pt 1):G319–24.
5.
go back to reference Lin Y, Dueker SR, Follett JR, Fadel JG, Arjomand A, Schneider PD, Miller JW, Green R, Buchholz BA, Vogel JS, Phair RD, Clifford AJ. Quantitation of in vivo human folate metabolism. Am J Clin Nutr. 2004;80(3):680–91.CrossRefPubMed Lin Y, Dueker SR, Follett JR, Fadel JG, Arjomand A, Schneider PD, Miller JW, Green R, Buchholz BA, Vogel JS, Phair RD, Clifford AJ. Quantitation of in vivo human folate metabolism. Am J Clin Nutr. 2004;80(3):680–91.CrossRefPubMed
6.
go back to reference Lindenbaum J, Allen RHA. Clinical spectrum and diagnosis of folate deficiency. In: Bailey LB, editor. Folate in health and disease. New York: Marcel Dekker; 1995. Lindenbaum J, Allen RHA. Clinical spectrum and diagnosis of folate deficiency. In: Bailey LB, editor. Folate in health and disease. New York: Marcel Dekker; 1995.
7.
go back to reference Stabler SP. Clinical folate deficiency. In: Bailey LB, editor. Folate in health and disease, 2nd edn. Boca Raton: CRC Press; 2009. Stabler SP. Clinical folate deficiency. In: Bailey LB, editor. Folate in health and disease, 2nd edn. Boca Raton: CRC Press; 2009.
8.
go back to reference Pietrzik K, Lamers Y, Brämswig S, Prinz-Langenohl R. Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women of childbearing age. Am J Clin Nutr. 2007;86(5):1414–9.CrossRefPubMed Pietrzik K, Lamers Y, Brämswig S, Prinz-Langenohl R. Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women of childbearing age. Am J Clin Nutr. 2007;86(5):1414–9.CrossRefPubMed
9.
go back to reference Gregory JF 3rd, da Silva VR, Lamers Y. Kinetics of folate and one-carbon metabolism. In: Bailey LB, editor. Folate in health and disease, 2nd edn. Boca Raton: CRC Press; 2009. Gregory JF 3rd, da Silva VR, Lamers Y. Kinetics of folate and one-carbon metabolism. In: Bailey LB, editor. Folate in health and disease, 2nd edn. Boca Raton: CRC Press; 2009.
10.
go back to reference Golding PH. Severe experimental folate deficiency in a human subject – a longitudinal study of biochemical and haematological responses as megaloblastic anaemia develops. SpringerPlus. 2014;3:442.CrossRefPubMedPubMedCentral Golding PH. Severe experimental folate deficiency in a human subject – a longitudinal study of biochemical and haematological responses as megaloblastic anaemia develops. SpringerPlus. 2014;3:442.CrossRefPubMedPubMedCentral
11.
go back to reference Hoffbrand AV, Provan D (2007) Macrocytic anaemias. In: ABC of clinical haematology. BMJ Publishing, London, pp 6–10. Hoffbrand AV, Provan D (2007) Macrocytic anaemias. In: ABC of clinical haematology. BMJ Publishing, London, pp 6–10.
12.
go back to reference Brown A. The anaemia of scurvy. Glasgow Med J. 1951;32(4):95–109.PubMed Brown A. The anaemia of scurvy. Glasgow Med J. 1951;32(4):95–109.PubMed
13.
go back to reference Brown A. Megaloblastic anaemia associated with adult scurvy: report of a case which responded to synthetic ascorbic acid alone. Br J Haematol. 1955;1(4):345–51.CrossRefPubMed Brown A. Megaloblastic anaemia associated with adult scurvy: report of a case which responded to synthetic ascorbic acid alone. Br J Haematol. 1955;1(4):345–51.CrossRefPubMed
14.
go back to reference Mueller JF, Will JJ. Interrelationship of folic acid, vitamin B12 and ascorbic acid in patients with megaloblastic anemia. Am J Clin Nutr. 1955;3(1):30–44.CrossRefPubMed Mueller JF, Will JJ. Interrelationship of folic acid, vitamin B12 and ascorbic acid in patients with megaloblastic anemia. Am J Clin Nutr. 1955;3(1):30–44.CrossRefPubMed
16.
17.
go back to reference Asquith P, Oelbaum MH, Dawson DW (1967) Scorbutic megaloblastic anaemia responding to ascorbic acid alone. Br Med J 18;4(5576):402. Asquith P, Oelbaum MH, Dawson DW (1967) Scorbutic megaloblastic anaemia responding to ascorbic acid alone. Br Med J 18;4(5576):402.
18.
go back to reference Zalusky R, Herbert V. Megaloblastic anemia in scurvy with response to 50 microgm. Of folic acid daily. N Engl J Med. 1961;265:1033–8.CrossRefPubMed Zalusky R, Herbert V. Megaloblastic anemia in scurvy with response to 50 microgm. Of folic acid daily. N Engl J Med. 1961;265:1033–8.CrossRefPubMed
19.
go back to reference Stokes PL, Melikian V, Leeming RL, Portman-Graham H, Blair JA, Cooke WT. Folate metabolism in scurvy. Am J Clin Nutr. 1975;28:126–9.CrossRefPubMed Stokes PL, Melikian V, Leeming RL, Portman-Graham H, Blair JA, Cooke WT. Folate metabolism in scurvy. Am J Clin Nutr. 1975;28:126–9.CrossRefPubMed
20.
go back to reference Jacob RA, Otradovec CL, Russell RM, Munro HN, Hartz SC, McGandy RB, Morrow FD, Sadowski JA. Vitamin C status and nutrient interactions in a healthy elderly population. Am J Clin Nutr. 1988;48(6):1436–42.CrossRefPubMed Jacob RA, Otradovec CL, Russell RM, Munro HN, Hartz SC, McGandy RB, Morrow FD, Sadowski JA. Vitamin C status and nutrient interactions in a healthy elderly population. Am J Clin Nutr. 1988;48(6):1436–42.CrossRefPubMed
21.
go back to reference Cafolla A, Dragoni F, Girelli G, Tosti ME, Costante A, De Luca AM, Funaro D, Scott CS. Effect of folic acid and vitamin C supplementation on folate status and homocysteine level: a randomised controlled trial in Italian smoker-blood donors. Atherosclerosis. 2002;163(1):105–11.CrossRefPubMed Cafolla A, Dragoni F, Girelli G, Tosti ME, Costante A, De Luca AM, Funaro D, Scott CS. Effect of folic acid and vitamin C supplementation on folate status and homocysteine level: a randomised controlled trial in Italian smoker-blood donors. Atherosclerosis. 2002;163(1):105–11.CrossRefPubMed
22.
go back to reference Verlinde PH, Oey I, Hendrickx ME, Van Loey AM, Temme EH. L-ascorbic acid improves the serum folate response to an oral dose of [6S]-5-methyltetrahydrofolic acid in healthy men. Eur J Clin Nutr. 2008;62(10):1224–30.CrossRefPubMed Verlinde PH, Oey I, Hendrickx ME, Van Loey AM, Temme EH. L-ascorbic acid improves the serum folate response to an oral dose of [6S]-5-methyltetrahydrofolic acid in healthy men. Eur J Clin Nutr. 2008;62(10):1224–30.CrossRefPubMed
23.
go back to reference Lucock M, Yates Z, Boyd L, Naylor C, Choi JH, Ng X, Skinner V, Wai R, Kho J, Tang S, Roach P, Veysey M. Vitamin C-related nutrient-nutrient and nutrient-gene interactions that modify folate status. Eur J Nutr. 2013;52(2):569–82.CrossRefPubMed Lucock M, Yates Z, Boyd L, Naylor C, Choi JH, Ng X, Skinner V, Wai R, Kho J, Tang S, Roach P, Veysey M. Vitamin C-related nutrient-nutrient and nutrient-gene interactions that modify folate status. Eur J Nutr. 2013;52(2):569–82.CrossRefPubMed
24.
go back to reference Donaldson KO, Keresztesy JC. Naturally occurring forms of folic acid. III. Characterization and properties of 5-methyldihydrofolate, an oxidation product of 5-methyltetrahydrofolate. J Biol Chem. 1962;237:3815–9.PubMed Donaldson KO, Keresztesy JC. Naturally occurring forms of folic acid. III. Characterization and properties of 5-methyldihydrofolate, an oxidation product of 5-methyltetrahydrofolate. J Biol Chem. 1962;237:3815–9.PubMed
25.
go back to reference Lucock MD, Priestnall M, Daskalakis I, Schorah CJ, Wild J, Levene MI. Nonenzymatic degradation and salvage of dietary folate: physicochemical factors likely to influence bioavailability. Biochem Mol Med. 1995;55(1):43–53.CrossRefPubMed Lucock MD, Priestnall M, Daskalakis I, Schorah CJ, Wild J, Levene MI. Nonenzymatic degradation and salvage of dietary folate: physicochemical factors likely to influence bioavailability. Biochem Mol Med. 1995;55(1):43–53.CrossRefPubMed
26.
go back to reference Oey I, Verlinde P, Hendrickx M, et al. Temperature and pressure stability of l-ascorbic acid and/or [6s] 5-methyltetrahydrofolic acid: a kinetic study. Eur Food Res Technol. 2006;223:71.CrossRef Oey I, Verlinde P, Hendrickx M, et al. Temperature and pressure stability of l-ascorbic acid and/or [6s] 5-methyltetrahydrofolic acid: a kinetic study. Eur Food Res Technol. 2006;223:71.CrossRef
28.
go back to reference Ringling C, Rychlik M (2017) Simulation of food folate digestion and bioavailability of an oxidation product of 5-Methyltetrahydrofolate. Nutrients 1;9(9). pii: E969. Ringling C, Rychlik M (2017) Simulation of food folate digestion and bioavailability of an oxidation product of 5-Methyltetrahydrofolate. Nutrients 1;9(9). pii: E969.
29.
go back to reference McNulty H, Pentieva. Folate Bioavailability. In: Bailey LB, editor. Folate in Health and Disease. 2nd ed. Boca Raton: CRC Press; 2009. McNulty H, Pentieva. Folate Bioavailability. In: Bailey LB, editor. Folate in Health and Disease. 2nd ed. Boca Raton: CRC Press; 2009.
30.
go back to reference Garry PJ, Goodwin JS, Hunt WC, Gilbert BA. Nutritional status in a healthy elderly population: vitamin C. Am J Clin Nutr. 1982;36(2):332–9.CrossRefPubMed Garry PJ, Goodwin JS, Hunt WC, Gilbert BA. Nutritional status in a healthy elderly population: vitamin C. Am J Clin Nutr. 1982;36(2):332–9.CrossRefPubMed
31.
go back to reference Newton HM, Morgan DB, Schorah CJ, Hullin RP. Relation between intake and plasma concentration of vitamin C in elderly women. Br Med J (Clin Res Ed). 1983;287:1429.CrossRef Newton HM, Morgan DB, Schorah CJ, Hullin RP. Relation between intake and plasma concentration of vitamin C in elderly women. Br Med J (Clin Res Ed). 1983;287:1429.CrossRef
32.
go back to reference Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci. 1996;93(8):3704–9.CrossRefPubMedPubMedCentral Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci. 1996;93(8):3704–9.CrossRefPubMedPubMedCentral
33.
go back to reference Olson JA, Hodges RE. Recommended dietary intakes (RDI) of vitamin C in humans. Am J Clin Nutr. 1987;45(4):693–703.CrossRefPubMed Olson JA, Hodges RE. Recommended dietary intakes (RDI) of vitamin C in humans. Am J Clin Nutr. 1987;45(4):693–703.CrossRefPubMed
34.
go back to reference Carr AC, Pullar JM, Moran S, Vissers MC. Bioavailability of vitamin C from kiwifruit in non-smoking males: determination of healthy and optimal intakes. J Nutr Sci. 2012;1:e14.CrossRefPubMedPubMedCentral Carr AC, Pullar JM, Moran S, Vissers MC. Bioavailability of vitamin C from kiwifruit in non-smoking males: determination of healthy and optimal intakes. J Nutr Sci. 2012;1:e14.CrossRefPubMedPubMedCentral
35.
go back to reference Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr. 1999;69(6):1086–107.CrossRefPubMed Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr. 1999;69(6):1086–107.CrossRefPubMed
36.
37.
go back to reference Lykkesfeldt J, Poulsen HE. Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trials. Br J Nutr. 2010;103(9):1251–9.CrossRefPubMed Lykkesfeldt J, Poulsen HE. Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trials. Br J Nutr. 2010;103(9):1251–9.CrossRefPubMed
41.
go back to reference McCurdy PR, Dern RJ. Some therapeutic implications of ferrous sulfate-ascorbic acid mixtures. Am J Clin Nutr. 1968;21(4):284–8.CrossRefPubMed McCurdy PR, Dern RJ. Some therapeutic implications of ferrous sulfate-ascorbic acid mixtures. Am J Clin Nutr. 1968;21(4):284–8.CrossRefPubMed
42.
go back to reference Siegenberg D, Baynes RD, Bothwell TH, Macfarlane BJ, Lamparelli RD, Car NG, MacPhail P, Schmidt U, Tal A, Mayet F. Ascorbic acid prevents the dose-dependent inhibitory effects of polyphenols and phytates on nonheme-iron absorption. Am J Clin Nutr. 1991;53(2):537–41.CrossRefPubMed Siegenberg D, Baynes RD, Bothwell TH, Macfarlane BJ, Lamparelli RD, Car NG, MacPhail P, Schmidt U, Tal A, Mayet F. Ascorbic acid prevents the dose-dependent inhibitory effects of polyphenols and phytates on nonheme-iron absorption. Am J Clin Nutr. 1991;53(2):537–41.CrossRefPubMed
43.
go back to reference Hoffman KE, Yanelli K, Bridges KR. Ascorbic acid and iron metabolism: alterations in lysosomal function. Am J Clin Nutr. 1991;54(6 Suppl):1188S–92S.CrossRefPubMed Hoffman KE, Yanelli K, Bridges KR. Ascorbic acid and iron metabolism: alterations in lysosomal function. Am J Clin Nutr. 1991;54(6 Suppl):1188S–92S.CrossRefPubMed
45.
go back to reference Fisher AE, Naughton DP. Iron supplements: the quick fix with long-term consequences. Nutr J. 2004;16(3):2.CrossRef Fisher AE, Naughton DP. Iron supplements: the quick fix with long-term consequences. Nutr J. 2004;16(3):2.CrossRef
46.
go back to reference Shane B. Folate chemistry and metabolism. In: Bailey LB, editor. Folate in health and disease. 2nd ed. Boca Raton: CRC Press; 2009. Shane B. Folate chemistry and metabolism. In: Bailey LB, editor. Folate in health and disease. 2nd ed. Boca Raton: CRC Press; 2009.
47.
go back to reference Bates I, Lewis S. Reference ranges and normal values. In: Bain BJ, Bates I, Laffan MA, Lewis SM, editors. Dacie and Lewis practical haematology. 11th ed: Churchill Livingstone; 2012. Bates I, Lewis S. Reference ranges and normal values. In: Bain BJ, Bates I, Laffan MA, Lewis SM, editors. Dacie and Lewis practical haematology. 11th ed: Churchill Livingstone; 2012.
48.
go back to reference Levine M, Wang Y, Padayatty SJ, Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci U S A. 2001;98(17):9842–6.CrossRefPubMedPubMedCentral Levine M, Wang Y, Padayatty SJ, Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci U S A. 2001;98(17):9842–6.CrossRefPubMedPubMedCentral
Metadata
Title
Experimental folate deficiency in human subjects: what is the influence of vitamin C status on time taken to develop megaloblastic anaemia?
Author
Paul Henry Golding
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Hematology / Issue 1/2018
Electronic ISSN: 2052-1839
DOI
https://doi.org/10.1186/s12878-018-0107-2

Other articles of this Issue 1/2018

BMC Hematology 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.